Drug search by name

Factor IX (Recombinant [Glycopegylated]) and Thromboembolism

Result of checking the interaction of drug Factor IX (Recombinant [Glycopegylated]) and disease Thromboembolism for safety when used together.

Check result:

Factor IX (Recombinant [Glycopegylated]) <> Thromboembolism

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The brand name product, Kcentra of prothrombin complex is contraindicated in patients with disseminated intravascular coagulation (DIC). Both fatal and non-fatal arterial thromboembolic events (including acute myocardial infarction and arterial thrombosis), and venous thromboembolic events (including pulmonary embolism and venous thrombosis) and disseminated intravascular coagulation have been reported with the use of this product in clinical trials and post marketing surveillance. Exercise care if using this product in patients with a history of thromboembolic events.

Factor IX (Recombinant [Glycopegylated])

Generic Name: coagulation factor ix

Brand Name: Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Rebinyn, Rixubis, BeneFIX 250 Int'l Units, BeneFIX

Synonyms: Coagulation factor IX, Factor IX (Human)

What is Factor IX (Recombinant [Glycopegylated])?